Why is Valiant Laborato falling/rising?

As of 14-Aug, Valiant Laboratories Ltd is currently priced at 88.50, reflecting an increase of 0.25 or 0.28%. The stock has shown a trend reversal by gaining after two consecutive days of decline. Despite this recent uptick, Valiant Laboratories is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a generally bearish trend. The stock has underperformed significantly over the past month, with a decline of 21.54%, and has generated a return of -21.58% over the last year. However, the company has reported very positive results in its latest quarterly earnings, including a 160% growth in net profit and substantial increases in both profit before tax and net sales compared to previous quarters. This positive performance may have contributed to the recent price increase, despite the stock's overall weak long-term fundamentals and negative operating profits.
In the broader market context, Valiant Laboratories' short-term performance has been notably worse than the benchmark, with a 1-week return of -3.09% compared to a negligible decline of -0.03% for the Sensex. This consistent underperformance against the benchmark over the last three years, coupled with a weak long-term growth trajectory, suggests that while there may be short-term gains due to positive earnings reports, the stock remains risky and may not sustain its upward movement in the face of broader market trends and historical performance.